State of the Union updates: Trump spars with Dems, touts economy and immigration

President Trump urged the Stop Insider Trading Act to pass "without delay" to ensure that members of Congress do not "corruptly profit from using insider information."

His calls for legislation that would ban lawmakers from stock trading based on insider information received bipartisan cheers, followed by some laughing and partisan tension.

As some Democrats stood up and applauded, including Sen. Elizabeth Warren, Trump responded, "They stood up for that? I can't believe it."

"How about you first!" Rep. Mark Takano, a California Democrat, yelled after the president expressed surprise that the Democrats joined in the standing ovation.

"You're the most corrupt president!" Rep. Rashida Tlaib, a Michigan Democrat, also yelled.

"They stood up for that," Trump remarked. "Did Nancy Pelosi stand up, if she is here? Doubt it," the president quipped, drawing a collective "Woah!" from the Republican side of the aisle.

Former House Speaker Pelosi has faced allegations of trading on insider information during her time in Congress, but has denied any impropriety.

ABC News and The Associated Press contributed to this report

President Trump is using his speech to talk about health care, which is considered a key issue heading into November's elections.

Trump reiterated his desire to pay Americans directly to buy health insurance. He also called on Republicans, specifically House Speaker Mike Johnson and Senate Majority Leader John Thune, to codify his "most favored nation" policies -- which aim to ensure the U.S. isn't paying more than other countries for prescription drugs.

TRUMP CLAIM: "I took prescription drugs, a very big part of health care, from the highest price in the entire world to the lowest."

FACT CHECK: Needs more context

Trump has pointed to lower prescription drug prices, citing discount arrangements such as his new website, which provides manufacturer discount prices, TrumpRX and direct negotiations with manufacturers. Some targeted reductions have occurred for people paying the cash price without any insurance, but overall drug prices in the United States remain high, and many patients still face significant out-of-pocket costs.

The administration secured lower cash prices for certain high-profile medications, including weight-loss drugs such as Wegovy and Zepmound, largely for uninsured patients or those paying outside of traditional insurance coverage. Ben Jolley, the senior fellow for healthcare at the American Economic Liberties Project, noted that manufacturers were already under competitive and political pressure to reduce prices in that category as more products enter the market. In addition, those discounts applied to specific purchasing channels and did not necessarily translate into broad reductions in insured patients' costs or overall list prices.

Meanwhile, some of the most substantial recent price cuts are the result of policies enacted before Trump returned to office.

For example, at the start of this year, Bristol Myers Squibb reduced the price of the popular blood thinner Eliquis by more than 50%; Eli Lilly and their manufacturing partners dropped the price of diabetes drug Jardiance by 66%. Jolley said that those changes largely reflect the Medicare drug price negotiation.

With four Supreme Court justices seated in the front row, Trump criticized the Supreme Court's recent ruling striking down most of his global tariffs as illegal. The justices did not appear to react as Trump spoke.

Trump called the decision "unfortunate" and "disappointing," but said he'll move the policy forward under different legal authorities. The president also notably said he'll move forward with tariffs without action from Congress, despite Republican majorities in both chambers.

Democrats in the chambers applauded as Trump spoke about the Supreme Court rebuke.